name,category,termsactivating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,INTERPRO[450004309$IPR004827:Basic-leucine zipper (bZIP) transcription factor, 450010446$IPR011616:bZIP transcription factor, bZIP-1]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038883$hsa04912:GnRH signaling pathway, 470038905$hsa05215:Prostate cancer]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,PIR_SUPERFAMILY[630016200$PIRSF019614:cyclic AMP-dependent transcription factor, ATF4 type]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,SMART[760000306$SM00338:BRLZ]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000449$DNA binding, 790000466$dna-binding, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
activating transcription factor 4 (tax-responsive enhancer element B67); activating transcription factor 4C,UP_SEQ_FEATURE[850012981$chain:Cyclic AMP-dependent transcription factor ATF-4, 850102900$DNA-binding region:Basic motif, 850104712$domain:Leucine-zipper, 850105852$helix, 850106258$modified residue, 850112353$region of interest:Interaction with GABBR1, 850117294$sequence conflict, 850117295$sequence variant]
adhesion molecule with Ig-like domain 1,COG_ONTOLOGY[90000070$Function unknown]
adhesion molecule with Ig-like domain 1,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin]
adhesion molecule with Ig-like domain 1,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000357$SM00409:IG]
adhesion molecule with Ig-like domain 1,SP_PIR_KEYWORDS[790000256$cell adhesion, 790000267$cell projection, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001016$neurogenesis, 790001162$phosphoprotein, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
adhesion molecule with Ig-like domain 1,UP_SEQ_FEATURE[850005152$chain:Amphoterin-induced protein 1, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
bladder cancer associated protein,INTERPRO[450008692$IPR009598:Bladder cancer-related BC10, 450016321$IPR018015:Bladder cancer-related BC10-like]
bladder cancer associated protein,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000258$cell cycle, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
bladder cancer associated protein,UP_SEQ_FEATURE[850008164$chain:Bladder cancer-associated protein, 850118623$transmembrane region]
hepatoma-derived growth factor, related protein 3,INTERPRO[450000267$IPR000313:PWWP]
hepatoma-derived growth factor, related protein 3,SMART[760000264$SM00293:PWWP]
hepatoma-derived growth factor, related protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000434$differentiation, 790000616$glycoprotein, 790000632$growth factor, 790001065$nucleus, 790001162$phosphoprotein]
hepatoma-derived growth factor, related protein 3,UP_SEQ_FEATURE[850023522$chain:Hepatoma-derived growth factor-related protein 3, 850105126$domain:PWWP, 850106258$modified residue, 850117610$short sequence motif:Nuclear localization signal]
intermediate filament family orphan 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament]
intermediate filament family orphan 1,UP_SEQ_FEATURE[850026601$chain:Intermediate filament family orphan 1, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850117294$sequence conflict, 850118574$splice variant]
neuropeptide W,INTERPRO[450011933$IPR013297:Neuropeptide B/W precursor, 450011935$IPR013299:Neuropeptide W precursor]
neuropeptide W,SP_PIR_KEYWORDS[790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790001021$neuropeptide, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
neuropeptide W,UP_SEQ_FEATURE[850108409$peptide:Neuropeptide W-23, 850108410$peptide:Neuropeptide W-30, 850117295$sequence variant, 850117814$signal peptide]
nuclear receptor binding protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
nuclear receptor binding protein 2,UP_SEQ_FEATURE[850035065$chain:Nuclear receptor-binding protein 2, 850105086$domain:Protein kinase, 850118574$splice variant]
